---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-257001"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2023-10-16T23:59:59+00:00"
generated_at: "2026-06-09T23:28:13.549132+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma approves $273K bonus for CEO and $117K for Executive Director

## Summary
- Compensation Committee approved discretionary bonus of $273,000 for CEO Jerel Banks for FY 2023.
- Executive Director Megan Boston awarded $116,928 (converted from AUD at ~0.64 USD/AUD).
- Bonuses relate to performance during fiscal year ended June 30, 2023.

## SEC filing metadata
- accession: 0001193125-23-257001
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2023-10-16T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312523257001/0001193125-23-257001-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312523257001/d529125d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-257001
- JSON: https://secwatch.observer/filing/0001193125-23-257001.json
- Plain text: https://secwatch.observer/filing/0001193125-23-257001.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.